New label approved to reflect Thrombin-JMI manufacturing changes
FDA approves revised labeling for Thrombin-JMI.
Enhanced processes to reduce Factor V light chain content to undetectable levels during the manufacture of
Related Videos
Related Content
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023Article
A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023Article
According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.
